Table 2

Differences in disease complication prevalences between centers

ComplicationPrevalence by center, %
P
GothenbergStockholmFreiburgOxfordBrno
Iron deficiency 22 18 56 29 < .001 
Lymphadenopathy: persistent 23 42 < .001 
Splenomegaly 19 46 30 66 < .001 
Bronchiectasis 14 16 52 27 < .001 
No complications 43 46 24 12 < .001 
Lymphoid interstitial pneumonitis 10 < .001 
Hepatomegaly: unexplained 13 15 .008 
Granuloma: unexplained 10 16 .01 
Immune thrombocytopenia 12 13 .01 
Psoriasis .02 
Enteropathy: unexplained 10 13 15 .06 
Pernicious anemia 18 10 10 .08 
Autoimmune hemolytic anemia .08 
Thyrotoxicosis .26 
Hypothyroidism .28 
Persistent arthropathy .46 
Neutropenia .66 
Vitiligo 1.0 
ComplicationPrevalence by center, %
P
GothenbergStockholmFreiburgOxfordBrno
Iron deficiency 22 18 56 29 < .001 
Lymphadenopathy: persistent 23 42 < .001 
Splenomegaly 19 46 30 66 < .001 
Bronchiectasis 14 16 52 27 < .001 
No complications 43 46 24 12 < .001 
Lymphoid interstitial pneumonitis 10 < .001 
Hepatomegaly: unexplained 13 15 .008 
Granuloma: unexplained 10 16 .01 
Immune thrombocytopenia 12 13 .01 
Psoriasis .02 
Enteropathy: unexplained 10 13 15 .06 
Pernicious anemia 18 10 10 .08 
Autoimmune hemolytic anemia .08 
Thyrotoxicosis .26 
Hypothyroidism .28 
Persistent arthropathy .46 
Neutropenia .66 
Vitiligo 1.0 

The P value provides the statistical evidence against the hypothesis of equal intercenter rates for each disease complication.

Close Modal

or Create an Account

Close Modal
Close Modal